Sector: Health Care
Director information for AMICUS THERAPEUTICS INC (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Bradley L. Campbell | President and Chief Executive Officer | 49 | ["Over 20 years of experience in the Orphan Drug industry", "Led the global organization responsible for the commercialization of Galafold\u00ae", "Oversaw Technical Operations, Market Access, Program Management, Clinical Operations, and Regulatory Affairs functions", "Served on the Boards of Gennao Bio and ARYA Sciences Acquisition Corp III", "Experience at Progenics Pharmaceuticals", "Various commercial and business development roles at Genzyme and Bristol-Myers Squibb", "Strategy consultant for Marakon Associates", "B.A. in Public Policy Studies from Duke University", "M.B.A. from Harvard Business School"] | ["Corporate Advisory Board for the National Tay-Sachs and Allied Diseases Association", "Board of the Biotechnology Innovation Organization", "Duke-Margolis Advisory Board"] | 2025 |
| Burke W. Whitman | Chief Executive | 69 | ["34 years of military service", "U.S. Marine Corps general officer", "Corporate Chief Executive Officer", "Best CFO and Best CEO", "BA from Dartmouth College", "MBA from Harvard Business School", "Master of Strategic Studies from United States Army War College", "Master of Ministry from Nashotah House Theological Seminary"] | ["Audit and Compliance", "Nominating andCorporate Governance"] | 2025 |
| Craig A. Wheeler | CEO of Headwaters Biotech Advisors LLC | 64 | ["Former President and CEO of Momenta Pharmaceuticals", "Advisor to executives in the Biotech industry", "E&Y Entrepreneur of the Year Regional Award winner in 2011", "Former President of Chiron Biopharmaceuticals", "Experience in health care sector, especially pharma and biotech", "B.S. and M.S. in chemical engineering from Cornell University", "M.B.A. from the Wharton School of the University of Pennsylvania"] | ["Nominating andCorporate Governance"] | 2025 |
| Eiry W. Roberts, M.D. | Chief Medical Officer | 61 | ["former senior executive of Eli Lilly and Company", "over 25 years of pharmaceutical drug development experience", "Chair of the Medical Review Committee at Eli Lilly", "Adjunct Professor of Medicine at Indiana University", "non-profit Board experience"] | ["Medical Review Committee", "Healthcare Business Women\u2019s Association", "Springboard Ventures Steering Committee", "Indiana Health Forum", "Audit and Compliance", "Nominating andCorporate Governance"] | 2025 |
| Glenn P. Sblendorio | Chair of the Board of Directors | 69 | ["Former Chief Executive Officer and member of the Board of Directors of IVERIC bio, Inc.", "Former President and Chief Financial Officer of The Medicines Company", "Former Executive Vice President and Chief Financial Officer of Eyetech Pharmaceuticals, Inc.", "Former Managing Director of MPM Capital Advisors", "B.B.A. from Pace University", "M.B.A. from Fairleigh Dickinson University", "Graduate of the Harvard Advanced Management Program"] | ["Compensation and Leadership Development"] | 2025 |
| Lynn D. Bleil | Director | 61 | ["Led the West Coast Healthcare Practice of McKinsey & Company", "Core leader of McKinsey\u2019s worldwide Healthcare Practice", "Senior Partner at McKinsey & Company for 25 years", "Member of the Board of Directors of Sonova Holding AG", "Member of the Board of Directors of Alcon AG", "Prior directorships include DST Systems, Inc., Auspex Pharmaceuticals, and Stericycle, Inc.", "Chair of the Intermountain Wasatch Back Hospitals Community Board", "B.S.E. in Chemical Engineering from Princeton University", "M.B.A. from the Stanford Graduate School of Business"] | ["Audit and Compliance"] | 2025 |
| Margaret G. McGlynn | Chair of the Board of Directors | 65 | ["Retired from Merck & Company after 26 years", "President of Global Vaccines and Infectious Disease", "President, U.S. Hospital and Specialty Products", "Chief Executive Officer and President of The International AIDS Vaccine Initiative", "Executive leadership roles in global and U.S. marketing, sales, and managed care", "Chair of the Board of HCU Network America", "Trustee of University at Buffalo Foundation", "Holds a B.S. in Pharmacy and a M.B.A. in Marketing", "Honorary doctorate in sciences from the State University of New York at Buffalo"] | ["Compensation and Leadership Development"] | 2025 |
| Michael A. Kelly | Founder & President | 68 | ["Former senior executive of Amgen, Inc.", "More than two decades of executive experience in life sciences industry", "Former audit committee chairman for Direct Relief", "BSc in business administration from Florida A&M University"] | ["Audit Committee", "Audit and Compliance", "Nominating andCorporate Governance"] | 2025 |
| Michael G. Raab | Chair of the Board | ["President and Chief Executive Officer of Ardelyx, Inc.", "Partner of New Enterprise Associates", "Senior Vice President, Therapeutics and General Manager at Genzyme Corporation", "B.A. from DePauw University"] | ["Emerging Companies", "Health Section Governing Boards"] | 2025 | |
| Michael G. Raab (CH) | 60 | [] | ["Nominating andCorporate Governance"] | 2025 |
